The drug also diminished the relative frequencies of lymphocytic subpopulations in the spleen (CD4+/CD69+, CD8+/CD44high, and CD4+/CD25+/FoxP3+ cells) with potential roles in murine AIP [6,31]. The gene discussed is CD4; the disease is autoimmune pancreatitis.